Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients [CARE DELIVERY]

Conclusion: First-line carboplatin/etoposide is associated with similar survival and less subsequent hospital-based health care use than cisplatin/etoposide among elderly patients with ES SCLC treated in ambulatory settings.
Source: Journal of Oncology Practice - Category: Cancer & Oncology Authors: Tags: Quality of Care, Guidelines, Small Cell, Chemotherapy CARE DELIVERY Source Type: research